PICARAZZI, FRANCESCA

PICARAZZI, FRANCESCA  

Dipartimento di Biotecnologie, Chimica e Farmacia  

Mostra records
Risultati 1 - 12 di 12 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autore(i) File Abstract
A selective competitive inhibitor of aldehyde dehydrogenase 1A3 hinders cancer cell growth, invasiveness and stemness in vitro 1-gen-2021 Gelardi, E. L. M.; Colombo, G.; Picarazzi, F.; Ferraris, D. M.; Mangione, A.; Petrarolo, G.; Aronica, E.; Rizzi, M.; Mori, M.; La Motta, C.; Garavaglia, S. -
Conformational insights into the C-terminal mutations of human rhodopsin in retinitis pigmentosa 1-gen-2022 Picarazzi, Francesca; Manetti, Fabrizio; Marigo, Valeria; Mori, Mattia -
Design of small molecules interacting with wild-type and mutant rhodopsins 1-gen-2022 Picarazzi, Francesca -
DNA and RNA polymerases 1-gen-2024 Picarazzi, F.; Mori, M. -
Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro 1-gen-2020 Dragoni, F; Boccuto, A; Picarazzi, F; Giannini, A; Giammarino, F; Saladini, F; Mori, M; Mastrangelo, E; Zazzi, M; Vicenti, I. -
Experimental and Computational Druggability Exploration of the 14-3-3ζ/SOS1pS1161PPI Interface 1-gen-2020 Ballone, A.; Picarazzi, F.; Prosser, C.; Davis, J.; Ottmann, C.; Mori, M. -
Identification of Small Molecular Chaperones Binding P23H Mutant Opsin through an In Silico Structure-Based Approach 1-gen-2022 Picarazzi, Francesca; Zuanon, Marika; Pasqualetto, Gaia; Cammarone, Silvia; Romeo, Isabella; Young, Mark T; Brancale, Andrea; Bassetto, Marcella; Mori, Mattia -
Novel insights on human carbonic anhydrase inhibitors based on coumalic acid: design, synthesis, molecular modeling investigation, and biological studies 1-gen-2022 Pontecorvi, Virginia; Mori, Mattia; Picarazzi, Francesca; Zara, Susi; Carradori, Simone; Cataldi, Amelia; Angeli, Andrea; Berrino, Emanuela; Chimenti, Paola; Ciogli, Alessia; Secci, Daniela; Guglielmi, Paolo; Supuran, Claudiu T -
Novel pyrazolo[3,4-d]pyrimidines as dual Src/Bcr-Abl kinase inhibitors: synthesis and biological evaluation for chronic myeloid leukemia treatment 1-gen-2022 Di Maria, S.; Picarazzi, F.; Mori, M.; Cianciusi, A.; Carbone, A.; Crespan, E.; Perini, C.; Sabetta, S.; Deplano, S.; Poggialini, F.; Molinari, A.; Aronne, R.; Maccioni, E.; Maga, G.; Angelucci, A.; Schenone, S.; Musumeci, F.; Dreassi, E. -
SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells 1-gen-2022 Hammer, Q.; Dunst, J.; Christ, W.; Picarazzi, F.; Wendorff, M.; Momayyezi, P.; Huhn, O.; Netskar, H. K.; Maleki, K. T.; Garcia, M.; Sekine, T.; Sohlberg, E.; Azzimato, V.; Aouadi, M.; Degenhardt, F.; Franke, A.; Spallotta, F.; Mori, M.; Michaelsson, J.; Bjorkstrom, N. K.; Ruckert, T.; Romagnani, C.; Horowitz, A.; Klingstrom, J.; Ljunggren, H. -G.; Malmberg, K. -J. -
Sofosbuvir selects for drug-resistant amino acid variants in the zika virus RNA-dependent RNA-polymerase complex in vitro 1-gen-2021 Boccuto, A.; Dragoni, F.; Picarazzi, F.; Lai, A.; Ventura, C. D.; Veo, C.; Giammarino, F.; Saladini, F.; Zehender, G.; Zazzi, M.; Mori, M.; Vicenti, I. -
Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge 1-gen-2020 Picarazzi, F.; Vicenti, I.; Saladini, F.; Zazzi, M.; Mori, M. -